Table 1.
Laboratory findings before and after exenatide therapy.
| Before exenatide treatment | After exenatide treatment | P-value | |
|---|---|---|---|
| Triglyceride (mg/dL) | 174.02 ± 85.52 | 145.47 ± 50.52 | 0.019 |
| Total cholesterol (mg/dL) | 211.8 ± 43.38 | 183.23 ± 32.40 | <0.001 |
| HDL (mg/dL) | 48.77 ± 9.83 | 51.70 ± 9.62 | 0.034 |
| LDL (mg/dL) | 128.72 ± 38.64 | 103.00 ± 27.44 | <0.001 |
| non-HDL cholesterol (mg/dL) | 162.81 ± 40.42 | 132.63 ± 32.34 | <0.001 |
| FPG (mg/dL) | 155.13 ± 46.51 | 117.69 ± 26.10 | <0.001 |
| HbA1c (%) | 7.80 ± 1.31 | 6.71 ± 0.92 | <0.001 |
| hsCRP (mg/L) | 8.66 ± 6.02 | 5.16 ± 2.85 | <0.001 |
| Creatinin (mg/dL) | 0.77 ± 0.09 | 0.74 ± 0.10 | 0.074 |
| ALT (U/L) | 23 (10-99) | 19 (11-51) | <0.001 |
| AST (U/L) | 20 (12-70) | 19 (12-55) | 0.005 |
| GGT (U/L) | 49.40 ± 17.75 | 33.78 ± 8.26 | <0.001 |
HDL: high-density lipoprotein; LDL: low-density lipoprotein; FPG: fasting plasma glucose; HbA1c: glycated hemoglobin; ALT: alanin aminotransferase; AST: aspartate aminotransferase; GGT: gamma-glutamyl transferase.